Asia Pacific Fish Vaccines Market Forecast to 2030 - Regional Analysis - by Vaccine Type, Application, Route of Administration, and Species

List of Tables

The Asia Pacific fish vaccines market was valued at US$ 46.87 million in 2022 and is expected to reach US$ 94.15 million by 2030; it is estimated to grow at a CAGR of 9.1% from 2022 to 2030.

Development of Novel Fish Vaccine Fuels the Asia Pacific Fish Vaccine Market

Emergence of disease outbreak caused by parasites, viruses, and bacteria have slowed down the evolution of the global aquaculture industry for several decades. Aside from being harmful to human health, emerging diseases have a significant impact on aquatic animals. Traditional vaccines have limitations and drawbacks, which bolsters the demand for the development of novel advanced vaccines such as chimeric multiepitope vaccines. Newer avenues in the basic and applied research fields of aquatic vaccines have been opened up by scientific and technological advancements. An effort has been made to create novel aquatic vaccines with higher quality and efficiency using new technologies, approaches, and strategies.

Using the available bioinformatics tools and current knowledge of immunoproteomics and genomics, researchers can identify potential targeted epitopes that immune cells can recognize. Further, as the cost of techniques such as whole genome sequencing continues to decline, it opens the way for species-specific vaccine development. This is likely to boost investments in developing new vaccines. In 2021, the Central Institute of Brackishwater Aquaculture (ICAR) launched a recombinant vaccine against viral nervous necrosis (VNN) in India.

Thus, the development of an effective mucosal vaccine with strengthening the administration process is expected to accelerate the novel vaccine development, which would boost the aquaculture businesses in Mediterranean countries to regularize fish vaccination processes. Hence, development of novel fish vaccines is likely creating significant opportunity for market growth.

Asia Pacific Fish Vaccines Market Overview

The Asia Pacific fish vaccines market is segmented into China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific. The market growth in these countries is attributed to the rising aquaculture sector in the region and favorable government initiatives. Moreover, expansion and product launch strategies implemented by market players are expected to contribute to the growth of the fish vaccines market in the region. Commercial aquaculture production in Japan has developed dramatically since the end of the 2nd World War and occupies an important place in the fisheries sector. More than 60 species are included in the aquaculture section of the annual fisheries statistics. Of these, the main species are Nori, yesso scallop, oyster, Japanese amberjack, red seabream, and sea mustard. However, domestic demand for seafood products will decline in the next decade, and the production of aquaculture will decline if it remains dependent on domestic demand. This decline in demand in Japan is because Japan's population is dropping, and their diets are shifting toward meat.

Asia Pacific Fish Vaccines Market Revenue and Forecast to 2030 (US$ Million)

Asia Pacific Fish Vaccines Market Segmentation

The Asia Pacific fish vaccines market is segmented based on vaccine type, application, route of administration, species, and country.

Based on vaccine type, the Asia Pacific fish vaccines market is segmented into inactivated vaccines, live attenuated vaccines, subunit vaccines, recombinant vector vaccine, and others. The inactivated vaccines segment held the largest market share in 2022.

Based on application, the Asia Pacific fish vaccines market is segmented into bacterial infection, viral infection, and parasitic. The bacterial infection segment held the largest market share in 2022.

Based on route of administration, the Asia Pacific fish vaccines market is segmented into injection vaccine, immersion vaccine, and oral vaccine. The injection vaccine segment held the largest market share in 2022.

Based on species, the Asia Pacific fish vaccines market is segmented into salmon, trout, tilapia, and others. The salmon segment held the largest market share in 2022.

Based on country, the Asia Pacific fish vaccines market is segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. Japan dominated the Asia Pacific fish vaccines market share in 2022.

Choong Ang Vaccine Laboratories Co.; Elanco Animal Health Inc; Hipra SA; INDIAN IMMUNOLOGICALS LTD; KBNP Inc.; Kyoto Biken Laboratories; Merck & Co Inc.; Nisseiken Co., Ltd.; Phibro Animal Health Corp; Vaxxinova International BV; and Zoetis Inc. are some of the leading companies operating in the Asia Pacific fish vaccines market.

Product Code: BMIRE00029704

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Asia Pacific Fish Vaccine Market

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Asia Pacific Fish Vaccine Market - Key Industry Dynamics

4.1 Market Drivers:
- 4.1.1 Government Initiatives to Develop Aquaculture Industry
- 4.1.2 Surging Demand for Aquatic Animal-Derived Food Products
4.2 Market Restraints
- 4.2.1 Stringent Regulations for Approval of Vaccine
4.3 Market Opportunities
- 4.3.1 Development of Novel Fish Vaccine
4.4 Future Trends
- 4.4.1 Technological Advancements in Fish Vaccine
4.5 Impact Analysis:

5. Fish Vaccine Market - Asia Pacific Market Analysis

5.1 Fish Vaccine Market Revenue (US$ Th), 2022 - 2030

6. Asia Pacific Fish Vaccine Market - Revenue and Forecast to 2030 - by Vaccine Type

6.1 Overview
6.2 Fish Vaccine Market Revenue Share, by Vaccine Type, 2022 & 2030 (%)
6.3 Inactivated Vaccines
- 6.3.1 Overview
- 6.3.2 Inactivated Vaccines: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
6.4 Live Attenuated Vaccines
- 6.4.1 Overview
- 6.4.2 Live Attenuated Vaccines: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
6.5 Subunit Vaccines
- 6.5.1 Overview
- 6.5.2 Subunit Vaccines: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
6.6 Recombinant Vector Vaccine
- 6.6.1 Overview
- 6.6.2 Recombinant Vector Vaccine: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
6.7 Others
- 6.7.1 Overview
- 6.7.2 Others: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)

7. Asia Pacific Fish Vaccine Market - Revenue and Forecast to 2030 - by Application

7.1 Overview
7.2 Fish Vaccine Market Revenue Share, by Application, 2022 & 2030 (%)
7.3 Bacterial Infection
- 7.3.1 Overview
- 7.3.2 Bacterial Infection: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
7.4 Viral Infection
- 7.4.1 Overview
- 7.4.2 Viral Infection: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
7.5 Parasitic
- 7.5.1 Overview
- 7.5.2 Parasitic: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)

8. Asia Pacific Fish Vaccine Market - Revenue and Forecast to 2030 - by Route of Administration

8.1 Overview
8.2 Fish Vaccine Market Revenue Share, by Route of Administration, 2022 & 2030 (%)
8.3 Injection vaccine
- 8.3.1 Overview
- 8.3.2 Injection vaccine: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
8.4 Immersion Vaccine
- 8.4.1 Overview
- 8.4.2 Immersion Vaccine: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
8.5 Oral Vaccine
- 8.5.1 Overview
- 8.5.2 Oral Vaccine: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)

9. Asia Pacific Fish Vaccine Market - Revenue and Forecast to 2030 - by Species

9.1 Overview
9.2 Fish Vaccine Market Revenue Share, by Species, 2022 & 2030 (%)
9.3 Salmon
- 9.3.1 Overview
- 9.3.2 Salmon: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
9.4 Trout
- 9.4.1 Overview
- 9.4.2 Trout: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
9.5 Tilapia
- 9.5.1 Overview
- 9.5.2 Tilapia: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
9.6 Others
- 9.6.1 Overview
- 9.6.2 Others: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)

10. Asia Pacific Fish Vaccine Market - Country Analysis

10.1 Asia Pacific Fish Vaccine Market, Revenue and Forecast to 2030
- 10.1.1 Overview
- 10.1.2 Asia Pacific Fish Vaccine Market, by Country
  - 10.1.2.1 China
    - 10.1.2.1.1 Overview
    - 10.1.2.1.2 China Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
    - 10.1.2.1.3 China: Fish Vaccine Market, by Vaccine Type, 2020-2030 (US$ Thousand)
    - 10.1.2.1.4 China: Fish Vaccine Market, by Route of Administration, 2020-2030 (US$ Thousand)
    - 10.1.2.1.5 China: Fish Vaccine Market, by Species, 2020-2030 (US$ Thousand)
    - 10.1.2.1.6 China: Fish Vaccine Market, by Application, 2020-2030 (US$ Thousand)
  - 10.1.2.2 Japan
    - 10.1.2.2.1 Overview
    - 10.1.2.2.2 Japan Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
    - 10.1.2.2.3 Japan: Fish Vaccine Market, by Vaccine Type, 2020-2030 (US$ Thousand)
    - 10.1.2.2.4 Japan: Fish Vaccine Market, by Route of Administration, 2020-2030 (US$ Thousand)
    - 10.1.2.2.5 Japan: Fish Vaccine Market, by Species, 2020-2030 (US$ Thousand)
    - 10.1.2.2.6 Japan: Fish Vaccine Market, by Application, 2020-2030 (US$ Thousand)
  - 10.1.2.3 India
    - 10.1.2.3.1 Overview
    - 10.1.2.3.2 India Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
    - 10.1.2.3.3 India: Fish Vaccine Market, by Vaccine Type, 2020-2030 (US$ Thousand)
    - 10.1.2.3.4 India: Fish Vaccine Market, by Route of Administration, 2020-2030 (US$ Thousand)
    - 10.1.2.3.5 India: Fish Vaccine Market, by Species, 2020-2030 (US$ Thousand)
    - 10.1.2.3.6 India: Fish Vaccine Market, by Application, 2020-2030 (US$ Thousand)
  - 10.1.2.4 Australia
    - 10.1.2.4.1 Overview
    - 10.1.2.4.2 Australia Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
    - 10.1.2.4.3 Australia: Fish Vaccine Market, by Vaccine Type, 2020-2030 (US$ Thousand)
    - 10.1.2.4.4 Australia: Fish Vaccine Market, by Route of Administration, 2020-2030 (US$ Thousand)
    - 10.1.2.4.5 Australia: Fish Vaccine Market, by Species, 2020-2030 (US$ Thousand)
    - 10.1.2.4.6 Australia: Fish Vaccine Market, by Application, 2020-2030 (US$ Thousand)
  - 10.1.2.5 South Korea
    - 10.1.2.5.1 Overview
    - 10.1.2.5.2 South Korea Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
    - 10.1.2.5.3 South Korea: Fish Vaccine Market, by Vaccine Type, 2020-2030 (US$ Thousand)
    - 10.1.2.5.4 South Korea: Fish Vaccine Market, by Route of Administration, 2020-2030 (US$ Thousand)
    - 10.1.2.5.5 South Korea: Fish Vaccine Market, by Species, 2020-2030 (US$ Thousand)
    - 10.1.2.5.6 South Korea: Fish Vaccine Market, by Application, 2020-2030 (US$ Thousand)
  - 10.1.2.6 Rest of Asia Pacific
    - 10.1.2.6.1 Overview
    - 10.1.2.6.2 Rest of Asia Pacific Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
    - 10.1.2.6.3 Rest of Asia Pacific: Fish Vaccine Market, by Vaccine Type, 2020-2030 (US$ Thousand)
    - 10.1.2.6.4 Rest of Asia Pacific: Fish Vaccine Market, by Route of Administration, 2020-2030 (US$ Thousand)
    - 10.1.2.6.5 Rest of Asia Pacific: Fish Vaccine Market, by Species, 2020-2030 (US$ Thousand)
    - 10.1.2.6.6 Rest of Asia Pacific: Fish Vaccine Market, by Application, 2020-2030 (US$ Thousand)

11. Fish Vaccine Market - Industry Landscape

11.1 Overview
11.2 Growth Strategies in Fish Vaccine Market
11.3 Inorganic Growth Strategies
- 11.3.1 Overview
11.4 Organic Growth Strategies
- 11.4.1 Overview

12. Company Profiles

12.1 Zoetis Inc
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 Merck & Co Inc
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 HIPRA SA
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 Phibro Animal Health Corp
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 Vaxxinova International BV
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 Kyoto Biken Laboratories Inc
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
12.7 Elanco Animal Health Inc
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
12.8 Nisseiken Co Ltd
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
12.9 KBNP Inc
- 12.9.1 Key Facts
- 12.9.2 Business Description
- 12.9.3 Products and Services
- 12.9.4 Financial Overview
- 12.9.5 SWOT Analysis
- 12.9.6 Key Developments
12.10 Choong Ang Vaccine Laboratory
- 12.10.1 Key Facts
- 12.10.2 Business Description
- 12.10.3 Products and Services
- 12.10.4 Financial Overview
- 12.10.5 SWOT Analysis
- 12.10.6 Key Developments
12.11 Indian Immunologicals Ltd
- 12.11.1 Key Facts
- 12.11.2 Business Description
- 12.11.3 Products and Services
- 12.11.4 Financial Overview
- 12.11.5 SWOT Analysis
- 12.11.6 Key Developments

13. Appendix

13.1 About Us
13.2 Glossary of Terms